HUTCHMED (China) Ltd (HCM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.61 is considered Undervalued compared with the five-year average of 19.36. The fair price of HUTCHMED (China) Ltd (HCM) is between 38.50 to 62.62 according to relative valuation method. Compared to the current price of 13.89 USD , HUTCHMED (China) Ltd By Undervalued By 63.91%.

Relative Value

Fair Zone

38.50-62.62

Current Price：13.89

63.91%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is HUTCHMED (China) Ltd (HCM) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

HUTCHMED (China) Ltd (HCM) has a current Price-to-Book (P/B) ratio of 9.54. Compared to its 3-year average P/B ratio of 7.96, the current P/B ratio is approximately 19.88% higher. Relative to its 5-year average P/B ratio of 6.63, the current P/B ratio is about 43.99% higher. HUTCHMED (China) Ltd (HCM) has a Forward Free Cash Flow (FCF) yield of approximately -2.10%. Compared to its 3-year average FCF yield of -0.80%, the current FCF yield is approximately 163.25% lower. Relative to its 5-year average FCF yield of -3.60%, the current FCF yield is about -41.52% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for HCM competitors is 37.85, providing a benchmark for relative valuation. HUTCHMED (China) Ltd Corp (HCM.O) exhibits a P/S ratio of 3.61, which is -90.47% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of HCM increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of HCM in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is HCM currently overvalued or undervalued?

What is HUTCHMED (China) Ltd (HCM) fair value?

HCM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of HUTCHMED (China) Ltd (HCM) is between 38.50 to 62.62 according to relative valuation method.

How does HCM's valuation metrics compare to the industry average?

The average P/S ratio for HCM's competitors is 37.85, providing a benchmark for relative valuation. HUTCHMED (China) Ltd Corp (HCM) exhibits a P/S ratio of 3.61, which is -90.47% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for HUTCHMED (China) Ltd (HCM) as of Mar 02 2026?

As of Mar 02 2026, HUTCHMED (China) Ltd (HCM) has a P/B ratio of 9.54. This indicates that the market values HCM at 9.54 times its book value.

What is the current FCF Yield for HUTCHMED (China) Ltd (HCM) as of Mar 02 2026?

As of Mar 02 2026, HUTCHMED (China) Ltd (HCM) has a FCF Yield of -2.10%. This means that for every dollar of HUTCHMED (China) Ltd's market capitalization, the company generates -2.10 cents in free cash flow.

What is the current Forward P/E ratio for HUTCHMED (China) Ltd (HCM) as of Mar 02 2026?

As of Mar 02 2026, HUTCHMED (China) Ltd (HCM) has a Forward P/E ratio of 14.28. This means the market is willing to pay $14.28 for every dollar of HUTCHMED (China) Ltd's expected earnings over the next 12 months.

What is the current Forward P/S ratio for HUTCHMED (China) Ltd (HCM) as of Mar 02 2026?

As of Mar 02 2026, HUTCHMED (China) Ltd (HCM) has a Forward P/S ratio of 3.61. This means the market is valuing HCM at $3.61 for every dollar of expected revenue over the next 12 months.

HCM Valuation